A new study analyzed mutations of the 2009 pandemic influenza A(H1N1) virus in Japan, identifying unique triple combination of bird, swine, and human flu viruses. The research revealed rapid mutation of virus strains with an extremely high evolutionary rate, paving the way for the development of new diagnostic kits.
A study found that individuals with asymptomatic herpes simplex virus type 2 (HSV-2) infection can still shed the virus, highlighting a high risk of transmission to unsuspecting sexual partners. This poses a significant concern for public health and patient management.
Researchers at Dana-Farber Cancer Institute have identified a promising target for an AIDS vaccine: the V3 loop of the virus's protein envelope. Immune system antibodies aimed at this loop may offer protection against multiple genetic subtypes of HIV-1, offering hope for a universally effective vaccine.
Researchers have identified a new virus as the cause of deadly outbreaks in six Chinese provinces, with a mortality rate of 12%. The virus, known as Severe Fever with Thrombocytopenia Syndrome virus, is transmitted through tick bites and affects humans without causing human-to-human transmission.
A team of researchers has made significant strides in understanding the life cycle of flaviviruses, including the dengue fever virus, which causes viral hemorrhagic fever and affects millions worldwide. The study provides new insights into the molecular details of viral replication and interactions with host cells.
Researchers identified a gene that allows the Rubella virus to block cell death and created a mutant version that slows its spread. This discovery could lead to new tools for preventing rapid disease transmission if applicable to other viruses.
Researchers at UNC Health Care discovered the Kaposi sarcoma virus produces a homolog protein that binds to cellular proteins, preventing inflammatory response and allowing the virus to evade immune system detection. The study highlights the virus's ability to lie dormant in the body over a lifetime by avoiding cell death.
Researchers at the University of Illinois Chicago have discovered a family of small molecules that bind to the Ebola virus's outer protein coat and inhibit its entry into human cells. The findings demonstrate a potential breakthrough in preventing Ebola infection, with further studies planned to confirm efficacy.
A study by researchers at Ohio State University found that an enzyme-armed virus can spread more effectively through brain tumors and improve survival rates. The enzyme helps the virus clear a path through protein molecules, allowing it to destroy cancer cells more efficiently.
Researchers have discovered the molecular mechanism of measles virus infection, which could lead to a targeted cancer therapy. The study found that modifying the attachment protein is crucial for infectivity, and this discovery brings the dream of using measles virus as a cancer weapon closer to reality.
A new study published in Retrovirology reveals that cell samples used in previous research were contaminated with XMRV, not the cause of chronic fatigue syndrome. The researchers developed improved methods to detect XMRV and rule out infection by this virus as a cause of the disease.
A head-to-head trial found that the adjuvanted split-virus vaccine achieved a more rapid and stronger immune response than the whole-virus vaccine. In young adults, a single dose of the adjuvanted vaccine induced early seroprotection within one week, suggesting potential for reduced dosing frequency.
A new type of vaccine is being developed that can trick the body into developing immunity against polio, with no risk of causing or spreading the disease. The replica virus particle will be designed to look and behave like the real virus but contain no genetic material.
Early and abundant HIV antibodies are ineffective in blocking infection due to their inability to recognize the virus until it has invaded a healthy cell. The study reveals that the virus creates two versions of the 'Achilles heel' that different types of antibodies need to target, making effective defense challenging.
The structure of Lassa virus protein reveals how it evades the host's immune system and hijacks infected cells' machinery. Scientists discovered a unique mechanism called cap-stealing, where the virus steals the host cell's RNA cap to suppress interferon production.
Researchers discovered a virus component, P19, that can introduce foreign genes into plants without harming them. This technology has potential applications in pharmaceutical development and biotechnology.
Researchers at the University of Illinois have discovered a new virus in switchgrass that can cause mosaic and yellow streak symptoms, reducing photosynthesis and biomass yield. The virus, Marafivirus, is related to Maize rayado fino virus and has the potential to affect other crops.
Researchers have discovered how an antibody binds to West Nile virus, neutralizing it by crosslinking protein molecules. This 'locking up' prevents the virus from infecting host cells, making it a potential target for vaccine development.
Researchers have discovered the world's largest marine virus, Cafeteria roenbergensis virus, which has a genome larger than some cellular organisms. This complex 'mimi-like' virus infects an ecologically important planktonic predator and challenges the traditional boundary between living and non-living entities.
Researchers at Iowa State University and the Ames Laboratory discovered the flu virus uses a shuttle mechanism to relay protons through a channel, necessary for infection. This finding may lead to designing drugs that stop protons from moving through the channel.
Scientists from Brigham Young University and Florida State University have made a breakthrough in understanding the flu virus's structure, identifying a potential drug target. By mapping the M2 channel's atomic level details, researchers can now develop new treatments that can defeat the virus regardless of its mutations.
Researchers are conducting a phase II clinical trial using reovirus, a common virus that causes mild symptoms, to target and kill specific tumor cells with KRAS or EGFR mutations. The goal is to exploit the virus's ability to replicate in cancer cells while minimizing harm to healthy cells.
The study found that H5N1 survives longer at cooler temperatures and low humidity, persisting up to two weeks. The virus also thrives on certain surfaces like glass and steel, potentially surviving for up to two months.
A Texas Tech University biologist has identified a possible cause of the sudden death of bee colonies across North America: a combination of an insect virus and a fungus. The researchers' study published in PLOS ONE found an association between the two pathogens and high mortality rates among bees.
Scientists estimate that at least 183 million Americans have immunity to the 2009 pandemic H1N1 virus due to exposure or vaccination. They predict the virus will persist in a form causing relatively few deaths, but caution against complacency and urge influenza vaccination for all ages.
Experts speculate on future of H1N1 pandemic virus, predicting low mortality rates due to existing immunity in the population. The degree of immunity and potential changes to the virus will impact the upcoming influenza season.
Researchers at Cardiff University cloned a human virus, Human Cytomegalovirus (HCMV), which is a major cause of congenital malformations and life-threatening disease in transplant patients. The cloning of HCMV has enabled the development of new treatments and vaccines against this virus.
Researchers found HIV-1 virus alters in semen versus blood through two distinct mechanisms, affecting its replication and transmission.
Researchers found two mechanisms altering HIV-1 population in semen, including clonal amplification and compartmentalization. The study suggests the viral population in semen may be distinct from that in blood, affecting our understanding of transmission and selective pressures.
Researchers are testing a new drug therapy, MGAWN1, to treat individuals with West Nile fever or suspected central nervous system infection. The treatment has the potential to neutralize the virus and reduce complications associated with the disease.
Researchers discovered that the H1N1 flu virus used a novel amino acid location to adapt to human cells, allowing it to spread efficiently. This finding provides new insight into the biology of flu viruses and reveals a genetic marker for predicting future pandemics.
A new method of attack against the AIDS virus has been developed using a prevention system that stiffens cell membranes, making them impenetrable to the virus. This research, published in Chemistry & Biology, provides a novel focus on regulating cell membrane fluidity and preventing viral fusion.
Scientists at Tufts University and the University of Pennsylvania have determined the unusual structure of a key member of the herpes virus protein complex that allows it to invade cells. The research provides a new target for antiviral drugs, which could prevent the virus's access to cells.
Researchers at the University of Edinburgh have developed a method to alter viral conditions, reducing mutation and building resistance. This approach can target multiple viruses simultaneously and is being explored for use in treating influenza.
Scientists have mapped the herpes virus protein complex that allows it to invade cells, revealing a new target for antiviral drugs. This breakthrough could lead to the development of new therapeutics to restrict herpes virus access to mammalian cells.
Scientists at TWINCORE have developed a mouse-adapted version of the hepatitis C virus, allowing researchers to study its interaction with the immune system. This breakthrough enables the development of new vaccines and treatments for this chronic infection.
A 2009 H1N1 pandemic influenza vaccine has been found to protect mice from the 1918 Spanish flu virus. The study's results suggest that people vaccinated against 2009 H1N1 or exposed to the virus may have cross-protective antibodies against the 1918 strain, providing potential protection.
Researchers found that the 2009 H1N1 influenza vaccine may also protect against the lethal 1918 Spanish influenza virus, alleviating bioterrorism concerns. The study demonstrates cross-protection, showing that people vaccinated against H1N1 may also be protected against 1918.
Scientists uncover the flu's secret formula for evolving within host species: balance. The virus replicates with enough mutations to spread but not so many that it leads to its demise.
Researchers at Mount Sinai School of Medicine have discovered a novel component of the influenza virus that may be the key to developing a universal anti-viral treatment. By inhibiting this component, replication and spread of the virus can be slowed or halted.
Researchers use a virus-induced gene silencing approach to study the function of genes in plants' aging processes. They found that modifying genes involved in ethylene production can delay senescence in cut flowers and potted plants.
Scientists have developed an immune-deficient mouse model to study CCHF virus behavior in humans, a significant step towards vaccine and antiviral development. The model can help evaluate the safety and effectiveness of potential treatments, addressing the lack of suitable animal models for testing.
A new study reveals that the human immune system's defences against dengue fever can actually help the virus infect more cells. This finding could lead to the development of an effective vaccine by avoiding certain antibodies produced in response to the virus.
A new HIV modeling system developed by Chinese researchers suggests that CD8+ T cells could be useful in developing an AIDS vaccine. The model incorporates random patterns in the virus' mutation and immune response, mirroring real-life clinical behavior.
Researchers found that vaccinated birds can shed vaccine virus to infect other birds, and live vaccines do not always protect against infection from other viral strains. The use of modified live virus vaccines may be increasing the diversity of Newcastle Disease viruses circulating in wild birds.
Researchers at the US Department of Agriculture's Animal Diseases Research Unit have discovered the viral life cycle of malignant catarrhal fever (MCF), a leading cause of disease in American bison. The virus undergoes several changes inside the animal's body, targeting specific cell types at different stages of its own life cycle.
Researchers found that pandemic influenza viruses from 1918 and 2009 share a structural detail that makes them susceptible to neutralization by the same antibodies. Vaccination with either virus can generate cross-reactive antibodies capable of neutralizing the other virus.
A new study suggests that mosquitoes, particularly Culex tarsalis, played a significant role in spreading West Nile virus across the US. The findings reveal that mosquitoes' flight patterns mimic the actual path of the virus's spread, contradicting previous assumptions that birds were primarily responsible.
A study by researchers at Johns Hopkins Bloomberg School of Public Health suggests that mosquitoes played a primary role in spreading West Nile virus westward across the US. Genetic analysis detected widespread movement by Culex tarsalis populations, which were congruent with the pattern of West Nile virus infection across the country.
Researchers found that CS-8958 resulted in higher survival rates and lower virus levels than oseltamivir in mouse models. The novel compound also protected mice from lethal H5N1 infection when given before or after exposure to the virus.
A new study found that genetic interactions between avian H5N1 influenza and human seasonal influenza viruses can create hybrid strains with increased virulence. The researchers identified a key gene segment, PB2, which is responsible for the increased pathogenicity.
Researchers have proven that subneutralizing levels of dengue virus antibodies exacerbate the disease, contradicting the normal function of antibodies. This finding has major implications for developing a vaccine against dengue virus, which annually infects 50-100 million people worldwide.
Researchers at Iowa State University's Ames Lab have discovered the binding site of antiviral drug amantadine on the flu virus. The study shows that amantadine blocks the flu virus by attaching to a site within a proton channel, preventing it from infecting healthy cells.
A recent study published in the Journal of Experimental Medicine reveals that type I interferons are essential for combating Chikungunya virus infection. The unexpected finding is that fibroblasts, not immune cells, produce the virus-fighting proteins during infection.
A common plant virus attracts aphids by elevating the odor cue of infected plants without changing it. The insects transmit the disease efficiently despite leaving quickly, implying a persistent mode of transmission beyond agriculture.
Scientists have developed an experimental VLP vaccine that protects macaques and mice against chikungunya virus, a debilitating disease with no current treatment. The vaccine, using non-infectious virus-like particles, elicits immune responses and provides complete protection from infection.
The BC Centre for Disease Control has launched a genomic surveillance project to study the evolution of the pandemic H1N1 flu virus in British Columbia. Researchers will compare the genetic sequences of BC's influenza viruses with those from other regions to understand how mass gatherings like the Olympics impact the virus' evolution.
A new study by Imperial College London discovered a virus called vaccinia spreading four times more quickly than previously believed. The virus uses a novel mechanism to spread rapidly between cells, making it harder to target with antiviral drugs.
Scientists tested 2009 and 1918 H1N1 virus strains on chickens and ducks without causing disease or symptoms. The results suggest that birds played no role in the spread of these pandemic viruses.
Scientists have discovered that plant viruses can be harnessed to carry genetic information into plant cells, which could lead to the development of crops with desirable traits. By stabilizing viral vector genes, researchers hope to improve crop yields and resistance.